Verity Sabin

544 total citations
21 papers, 372 citations indexed

About

Verity Sabin is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Verity Sabin has authored 21 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Verity Sabin's work include Neuropeptides and Animal Physiology (6 papers), Receptor Mechanisms and Signaling (5 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). Verity Sabin is often cited by papers focused on Neuropeptides and Animal Physiology (6 papers), Receptor Mechanisms and Signaling (5 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). Verity Sabin collaborates with scholars based in United Kingdom, United States and France. Verity Sabin's co-authors include Stephen R. Mack, George M. Buckley, Lewis Gowers, Kerry Jenkins, William R. Pitt, David M. Parry, Oliver Rausch, Alícia P. Higueruelo, Richard Davenport and Trevor Morgan and has published in prestigious journals such as Tetrahedron, Cancer Letters and Drug Discovery Today.

In The Last Decade

Verity Sabin

20 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verity Sabin United Kingdom 14 172 162 63 55 51 21 372
Snahel Patel United States 9 187 1.1× 86 0.5× 57 0.9× 46 0.8× 30 0.6× 10 325
Hitoshi Sakashita Japan 10 220 1.3× 80 0.5× 75 1.2× 50 0.9× 30 0.6× 19 409
Nalin L. Subasinghe United States 12 198 1.2× 238 1.5× 30 0.5× 49 0.9× 29 0.6× 17 419
Elizabeth A. Malloy United States 9 155 0.9× 189 1.2× 51 0.8× 69 1.3× 43 0.8× 10 370
Michael J. Pether United States 12 194 1.1× 131 0.8× 61 1.0× 35 0.6× 23 0.5× 16 331
Jee Sun Yang South Korea 13 240 1.4× 153 0.9× 43 0.7× 78 1.4× 25 0.5× 17 419
Alessia Graziano Italy 14 292 1.7× 210 1.3× 78 1.2× 47 0.9× 79 1.5× 21 467
Petra E. van der Wouden Netherlands 12 340 2.0× 89 0.5× 93 1.5× 116 2.1× 35 0.7× 21 517
Richard Heng Switzerland 12 256 1.5× 108 0.7× 70 1.1× 75 1.4× 15 0.3× 17 373
Lan Shen United States 12 241 1.4× 282 1.7× 26 0.4× 68 1.2× 35 0.7× 23 532

Countries citing papers authored by Verity Sabin

Since Specialization
Citations

This map shows the geographic impact of Verity Sabin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verity Sabin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verity Sabin more than expected).

Fields of papers citing papers by Verity Sabin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verity Sabin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verity Sabin. The network helps show where Verity Sabin may publish in the future.

Co-authorship network of co-authors of Verity Sabin

This figure shows the co-authorship network connecting the top 25 collaborators of Verity Sabin. A scholar is included among the top collaborators of Verity Sabin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verity Sabin. Verity Sabin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santiago-Gómez, Angélica, Bruno M. Simões, I. Dragoni, et al.. (2019). PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer. Cancer Letters. 458. 66–75. 25 indexed citations
2.
Buckley, George M., Richard Fosbeary, Lewis Gowers, et al.. (2008). IRAK-4 inhibitors. Part III: A series of imidazo[1,2-a]pyridines. Bioorganic & Medicinal Chemistry Letters. 18(12). 3656–3660. 38 indexed citations
3.
Buckley, George M., Lewis Gowers, Alícia P. Higueruelo, et al.. (2008). IRAK-4 inhibitors. Part 1: A series of amides. Bioorganic & Medicinal Chemistry Letters. 18(11). 3211–3214. 29 indexed citations
4.
Buckley, George M., T.A. Ceska, Lewis Gowers, et al.. (2008). IRAK-4 inhibitors. Part II: A structure-based assessment of imidazo[1,2-a]pyridine binding. Bioorganic & Medicinal Chemistry Letters. 18(11). 3291–3295. 38 indexed citations
5.
Perry, Benjamin, Gavin Bennett, George M. Buckley, et al.. (2008). Optimization of a series of multi-isoform PI3 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(19). 5299–5302. 9 indexed citations
6.
Buckley, George M., Alan F. Haughan, Kerry Jenkins, et al.. (2006). Low molecular weight indole fragments as IMPDH inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(9). 2535–2538. 15 indexed citations
7.
Buckley, George M., Alan F. Haughan, Kerry Jenkins, et al.. (2006). Novel indole inhibitors of IMPDH from fragments: Synthesis and initial structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 16(9). 2539–2542. 17 indexed citations
8.
Davenport, Richard, et al.. (2006). Novel nucleotide triphosphates as potent P2Y2 agonists with enhanced stability over UTP. Bioorganic & Medicinal Chemistry Letters. 17(2). 558–561. 8 indexed citations
9.
Davenport, Richard, Jeremy Davis, F Galvin, et al.. (2006). Novel nucleotide triphosphates as potent P2Y2 agonists. Bioorganic & Medicinal Chemistry Letters. 17(2). 562–565. 22 indexed citations
10.
Billah, Motasim, George M. Buckley, Nicola J. Cooper, et al.. (2002). 8-Methoxyquinolines as PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(12). 1617–1619. 18 indexed citations
11.
Buckley, George M., Nicola Cooper, Hazel J. Dyke, et al.. (2002). 8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma. Bioorganic & Medicinal Chemistry Letters. 12(12). 1613–1615. 12 indexed citations
12.
Buckley, George M., Nicola J. Cooper, Richard Davenport, et al.. (2002). 7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 Inhibitors: A Potential Treatment for Asthma. Bioorganic & Medicinal Chemistry Letters. 12(3). 509–512. 17 indexed citations
13.
Davenport, Richard, et al.. (2002). Synthesis of novel substituted isoquinolones. Tetrahedron. 58(29). 5761–5766. 24 indexed citations
14.
Buckley, George M., Nicola Cooper, Hazel J. Dyke, et al.. (2000). 7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma. Bioorganic & Medicinal Chemistry Letters. 10(18). 2137–2140. 15 indexed citations
15.
Swain, Christopher J., Eileen M. Seward, Margaret A. Cascieri, et al.. (1996). ChemInform Abstract: Identification of a Series of 3‐(Benzyloxy)‐1‐azabicyclo(2.2.2)octane Human NK1 Antagonists.. ChemInform. 27(14). 1 indexed citations
16.
Sabin, Verity. (1996). XIVth International Symposium on Medicinal Chemistry. Drug Discovery Today. 1(12). 498–500. 2 indexed citations
17.
Francis, B., Christopher J. Swain, Verity Sabin, & H. Donald Burns. (1994). Radioiodinated l-703,606: A potent, selective antagonist to the human NK1 receptor. Applied Radiation and Isotopes. 45(1). 97–103. 9 indexed citations
18.
Seward, Eileen M., Christopher J. Swain, Kevin J. Merchant, et al.. (1993). Quinuclidine-based NK-1 antagonists I: 3-benzyloxy-1-azabicyclo[2.2.2]octanes. Bioorganic & Medicinal Chemistry Letters. 3(6). 1361–1366. 26 indexed citations
19.
Swain, Christopher J., Eileen M. Seward, Verity Sabin, et al.. (1993). Quinuclidine based NK-1 antagonists 2: determination of the absolute stereochemical requirements. Bioorganic & Medicinal Chemistry Letters. 3(8). 1703–1706. 15 indexed citations
20.
Fleming, Ian, Trevor Newton, Verity Sabin, & Françoise Zammattio. (1992). The synthesis of 3-trimethylsilyl-4-dimethyl(phenyl)silylbut-3-en-2-one, a β-functionalised Michael acceptor. Tetrahedron. 48(37). 7793–7802. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Snahel Patel Breakdown of academic impact, for papers by Hitoshi Sakashita Breakdown of academic impact, for papers by Nalin L. Subasinghe Breakdown of academic impact, for papers by Elizabeth A. Malloy Breakdown of academic impact, for papers by Michael J. Pether Breakdown of academic impact, for papers by Jee Sun Yang Breakdown of academic impact, for papers by Alessia Graziano Breakdown of academic impact, for papers by Petra E. van der Wouden Breakdown of academic impact, for papers by Richard Heng Breakdown of academic impact, for papers by Lan Shen
Rankless by CCL
2026